KNSA Kiniksa Pharmaceuticals RESULTS: Q2, Q2 operating expenses $216.406M, Q2 Net Income $25.432M, Q2 pretax profit $31.145M, Kiniksa Pharma

KNSA Kiniksa Pharmaceuticals RESULTS: Q2, Q2 operating expenses $216.406M, Q2 Net Income $25.432M, Q2 pretax profit $31.145M, Kiniksa Pharmaceuticals Earnings Notes:, - Kiniksa Pharmaceuticals Q2 product REV $243.6M